High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer
Summary: Organoids allow the recapitulation of intestinal homeostasis and cancerogenesis in vitro; however, RNA sequencing (RNA-seq)-based methods for drug screens are missing. We develop targeted organoid sequencing (TORNADO-seq), a high-throughput, high-content drug discovery platform that uses ta...
Main Authors: | Maxim Norkin, Paloma Ordóñez-Morán, Joerg Huelsken |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-04-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124721003405 |
Similar Items
-
Patient-Derived Organoids in Precision Medicine: Drug Screening, Organoid-on-a-Chip and Living Organoid Biobank
by: Zilong Zhou, et al.
Published: (2021-12-01) -
Organoids in high-throughput and high-content screenings
by: Franziska L. Lampart, et al.
Published: (2023-03-01) -
Organoid Models of Glioblastoma and Their Role in Drug Discovery
by: Matthew J. Rybin, et al.
Published: (2021-02-01) -
Patient-Derived Organoids as a Model for Cancer Drug Discovery
by: Colin Rae, et al.
Published: (2021-03-01) -
The role of organoids in cancer research
by: Zhen Fang, et al.
Published: (2023-08-01)